A detailed history of Loomis Sayles & CO L P transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Loomis Sayles & CO L P holds 174,617 shares of ANIP stock, worth $9.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
174,617
Previous 181,448 3.76%
Holding current value
$9.84 Million
Previous $11.6 Million 9.84%
% of portfolio
0.01%
Previous 0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$54.33 - $65.72 $371,128 - $448,933
-6,831 Reduced 3.76%
174,617 $10.4 Million
Q2 2024

Aug 13, 2024

BUY
$58.53 - $68.82 $64,675 - $76,046
1,105 Added 0.61%
181,448 $11.6 Million
Q1 2024

May 14, 2024

SELL
$54.2 - $69.69 $4,661 - $5,993
-86 Reduced 0.05%
180,343 $12.5 Million
Q4 2023

Feb 13, 2024

BUY
$48.72 - $65.43 $740,544 - $994,536
15,200 Added 9.2%
180,429 $9.95 Million
Q3 2023

Nov 09, 2023

SELL
$50.28 - $64.61 $172,259 - $221,353
-3,426 Reduced 2.03%
165,229 $9.59 Million
Q2 2023

Aug 11, 2023

BUY
$37.29 - $53.83 $2.41 Million - $3.48 Million
64,643 Added 62.15%
168,655 $9.08 Million
Q1 2023

May 11, 2023

BUY
$37.61 - $45.72 $3.91 Million - $4.76 Million
104,012 New
104,012 $4.13 Million
Q4 2018

Feb 14, 2019

SELL
$41.17 - $56.44 $4,446 - $6,095
-108 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$53.3 - $74.56 $15,990 - $22,368
-300 Reduced 73.53%
108 $7,000
Q3 2017

Nov 14, 2017

BUY
$43.46 - $52.49 $1,347 - $1,627
31 Added 8.22%
408 $21,000
Q2 2017

Aug 14, 2017

BUY
N/A
377
377 $18,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.